UPDATE 2-U.S. FDA approves Bristol-Myers MS drug, launch delayed due to coronavirus
March 26, 2020 at 08:02 AM EDT
The U.S. Food and Drug Administration on Thursday approved Bristol-Myers Squibb Co's multiple sclerosis (MS) treatment, Zeposia, but its launch will be delayed due to the coronavirus outbreak, the drugmaker said.
